Filing Details
- Accession Number:
- 0001035267-24-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-29 19:17:15
- Reporting Period:
- 2024-02-28
- Accepted Time:
- 2024-02-29 19:17:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1035267 | Intuitive Surgical Inc | ISRG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 770416458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1252986 | Marshall Mohr | 1020 Kifer Road Sunnyvale CA 94086 | Executive Vp Global Business S | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-28 | 13,530 | $242.34 | 40,407 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 13,530 | $385.08 | 26,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 13,530 | $177.99 | 40,407 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 13,530 | $385.08 | 26,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 10,500 | $166.62 | 37,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 10,500 | $385.08 | 26,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 12,750 | $174.26 | 39,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 12,750 | $385.08 | 26,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 12,750 | $139.52 | 39,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 12,750 | $385.08 | 26,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 22,500 | $109.49 | 49,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 14,620 | $385.09 | 34,757 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 22,500 | $79.64 | 57,257 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 13,750 | $385.08 | 43,507 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 11,250 | $77.00 | 54,757 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 6,860 | $385.08 | 47,897 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-28 | 10,500 | $182.83 | 58,397 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-28 | 10,500 | $385.08 | 47,897 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 2,253 | $0.00 | 50,150 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-29 | 1,142 | $386.59 | 49,008 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-02-29 | 1,003 | $0.00 | 50,011 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-29 | 509 | $386.59 | 49,502 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 11,250 | $0.00 | 11,250 | $77.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 22,500 | $0.00 | 22,500 | $79.64 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 22,500 | $0.00 | 22,500 | $109.49 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 12,750 | $0.00 | 12,750 | $139.52 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 10,500 | $0.00 | 10,500 | $166.62 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 12,750 | $0.00 | 12,750 | $174.26 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 13,530 | $0.00 | 13,530 | $177.99 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 10,500 | $0.00 | 10,500 | $182.83 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2024-02-28 | 13,530 | $0.00 | 13,530 | $242.34 |
| Common Stock | Restricted Stock Units | Disposition | 2024-02-29 | 2,253 | $0.00 | 2,253 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2024-02-29 | 1,003 | $0.00 | 1,003 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-08-15 | No | 4 | M | Direct | |
| 0 | 2027-02-15 | No | 4 | M | Direct | |
| 0 | 2027-08-15 | No | 4 | M | Direct | |
| 0 | 2028-02-15 | No | 4 | M | Direct | |
| 0 | 2029-08-15 | No | 4 | M | Direct | |
| 0 | 2028-08-15 | No | 4 | M | Direct | |
| 0 | 2030-02-28 | No | 4 | M | Direct | |
| 0 | 2029-02-15 | No | 4 | M | Direct | |
| 0 | 2030-08-28 | No | 4 | M | Direct | |
| 0 | 2024-02-28 | No | 4 | M | Direct | |
| 2,004 | 2026-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100,353 | Indirect | by Trust |
Footnotes
- These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 15, 2024.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
- Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
- Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
- Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.
Billionaire Hedge Funds
